Abstract
1791P Effect of anlotinib in advanced small cell lung cancer (SCLC) patients with liver metastases: A subgroup analysis from a randomized, double-blind phase II trial (ALTER 1202)
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have